List Title | APhA DrugInfoLine

Oncology

SORT BY: Most Recent Most Viewed

January 12, 2014

Early lenalidomide improves multiple myeloma survival

READ

PREVIEW
In patients with high-risk smoldering multiple myeloma, early combination therapy with lenalidomide (Revlimid—Celgene) and dexamethasone delayed disease progression and increased overall...
December 16, 2013

Anastrozole lowers breast cancer incidence in high-risk women

READ

PREVIEW
In postmenopausal women at high risk for breast cancer, preventive treatment with anastrozole (Arimidex—AstraZeneca) for 5 years reduced the incidence of breast cancer by about 50% compared to...
November 4, 2013

Ponatinib safety concerns prompt FDA to suspend sales and marketing

READ

PREVIEW
In a phase 2 trial in individuals with resistant chronic myeloid leukemia or acute lymphocytic leukemia, ponatinib (Iclusig—Ariad Pharmaceuticals) demonstrated significant activity in multiple...
October 12, 2013

USPSTF updates recommendations for breast cancer prevention drugs

READ

PREVIEW
When used as primary prevention, tamoxifen and raloxifene (Evista—Lilly) reduced the incidence of invasive breast cancer and lowered fracture risk, according to a systematic analysis of existing...
September 27, 2013

Low-dose CT replacing X-ray as standard screening for lung cancer

READ

PREVIEW
More early-stage lung cancers were detected by low-dose computed tomography (CT) than by chest radiography, according to results from the National Lung Screening Trial (NLST). Findings suggest a...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.